EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PDE4D and PDE3B orchestrate distinct cAMP microdomains in 3T3‐L1 adipocytes

Johannes Krier, David Spähn, David Arturo Juarez Lopez, Judith L Nono, Judith Seigner, Lisa Jacob, Siegfried Ussar, Robert Lukowski, Andreas L Birkenfeld, Gencer Sancar iD

British Journal of Pharmacology · 13.10.2025

DOI: 10.1111/bph.70216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 13.10.2025. Verfasst von Johannes Krier und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University of Tübingen, Tübingen, Germany. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsches Zentrum für Diabetesforschung, German Center for Diabetes Research (DZD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Lipolysis is tightly regulated by pro‐lipolytic β ‐adrenoceptor signalling, which activates the cAMP/PKA pathway, and by antilipolytic hormones like insulin and FGF1, which counter‐regulate lipolysis through cAMP‐degrading phosphodiesterases (PDEs). While the spatial compartmentalization of cAMP signalling is recognized, comparisons between distinct cAMP pools remain under‐investigated in adipocytes. Moreover, the dynamics of cAMP around lipid droplets (LD) where lipolysis occurs, are particularly intriguing. Thus, we studied whether adipose FGF1/PDE4D and insulin/PDE3B pathways regulate distinct cAMP microdomains to execute their antilipolytic actions. Experimental Approach We evaluated the role of subcellular cAMP pools in lipolysis regulation by PDEs, or antilipolytic hormones, by utilizing EPAC1‐based FRET cAMP biosensors specifically designed to localize in the cytoplasm or at the plasma membrane of living cells. Additionally, we developed the first LD‐associated cAMP biosensor by fusing the lipid droplet‐associated protein perilipin‐1 to the EPAC1‐based probe. Key Results We identified previously unrecognized cAMP pools surrounding LDs that are distinct from cytoplasmic cAMP and resistant to PDE inhibition or antilipolytic stimuli. PDE4D exhibits a stronger effect on all three cAMP pools investigated than PDE3B. FGF1 mainly inhibits the cAMP in the initiation of the signalling at the plasma membrane, whereas insulin targets mainly cytoplasmic cAMP pools. Conclusion and Implications The discovery of LD‐associated cAMP as a distinct subcellular pool suggests that cAMP signalling in adipocytes is more compartmentalized than previously recognized. The distinct pathways by which FGF1 and insulin regulate adipose cell cAMP levels highlight that antilipolytic signalling is not uniform, refining our understanding of lipolysis regulation.

Schlagwörter

Stichwörter der Autor:innen

FGF1FRETPDE3BPDE4DcAMPinsulinlipolysis

Autor:innen und Institutionen

  • Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University of Tübingen, Tübingen, Germany.
  • Institute for Diabetes Research and Metabolic Diseases, Helmholtz Center Munich, University of Tübingen, Tübingen, Germany.
  • German Center for Diabetes Research (DZD), Neuherberg, Germany.
  • Institute of Pharmacy, Department of Pharmacology Toxicology and Clinical Pharmacy University of Tübingen, Tübingen, Germany.
  • Research Unit Adipocytes & Metabolism (ADM), Helmholtz Diabetes Center, Helmholtz Center Munich, German Research Center for Environmental Health GmbH, Neuherberg, Germany.

ORCID-Profile: Gencer Sancar

Förderung

  • Deutsche Forschungsgemeinschaft
  • Deutsches Zentrum für Diabetesforschung
  • German Center for Diabetes Research (DZD)

Zitieren

APA

Krier, J., Spähn, D., Lopez, D. A. J., Nono, J. L., Seigner, J., Jacob, L., Ussar, S., Lukowski, R., Birkenfeld, A. L., & Sancar, G. (2025). PDE4D and PDE3B orchestrate distinct cAMP microdomains in 3T3‐L1 adipocytes. British Journal of Pharmacology. https://doi.org/10.1111/bph.70216

Vancouver

Krier J, Spähn D, Lopez DAJ, Nono JL, Seigner J, Jacob L, et al. PDE4D and PDE3B orchestrate distinct cAMP microdomains in 3T3‐L1 adipocytes. British Journal of Pharmacology. 2025. doi:10.1111/bph.70216

BibTeX
@article{Krier2025,
  author = {Krier, Johannes and Spähn, David and Lopez, David Arturo Juarez and Nono, Judith L and Seigner, Judith and Jacob, Lisa and Ussar, Siegfried and Lukowski, Robert and Birkenfeld, Andreas L and Sancar, Gencer},
  title = {PDE4D and PDE3B orchestrate distinct cAMP microdomains in 3T3‐L1 adipocytes},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.70216}
}
Kostenlos starten →